trending Market Intelligence /marketintelligence/en/news-insights/trending/GYqIzPL9fzMMpISW4SG-DA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Jyothy Laboratories profit misses consensus by 45.3% in fiscal Q1

Blog

COVID-19 Impact & Recovery: LCD Outlook for H2 2021

Blog

COVID 19 Impact Recovery Media Telecom and Technology Outlook for H2 2021

Blog

COVID-19 Impact & Recovery: Technology Outlook for H2 2021

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Jyothy Laboratories profit misses consensus by 45.3% in fiscal Q1

Jyothy Laboratories Ltd said its normalized net income for the fiscal first quarter ended June 30 amounted to 1.78 Indian rupees per share, compared with the S&P Capital IQ consensus estimate of 3.25 rupees per share.

EPS climbed 20.8% year over year from 1.47 rupees.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 326.1 million rupees, a gain of 22.6% from 266.0 million rupees in the year-earlier period.

The normalized profit margin increased to 7.9% from 6.9% in the year-earlier period.

Total revenue increased 7.5% year over year to 4.14 billion rupees from 3.85 billion rupees, and total operating expenses grew 6.6% year over year to 3.64 billion rupees from 3.41 billion rupees.

Reported net income increased 5.0% from the prior-year period to 445.8 million rupees, or 2.43 rupees per share, from 424.6 million rupees, or 2.35 rupees per share.

As of July 30, US$1 was equivalent to 64.11 Indian rupees.